Evidence map›Paper›PMID 40841704›Full record

ArticleArchives of toxicology2025

Transcriptomic profile of TiO

Laeticia Perez, Jérôme Ambroise, Bertrand Bearzatto, Yousof Yakoub, Mihaly Palmai-Pallag, Caroline Bouzin, Laurence Ryelandt, Cristina Pavan, François Huaux, Dominique Lison

Abstract read
In one paragraph

Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laeticia PerezLouvain Centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium. laeticia.perez@uclouvain.be.ORCID 0009-0000-5697-5913
Jérôme AmbroiseCentre de Technologies Moléculaires Appliquées, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
Bertrand BearzattoCentre de Technologies Moléculaires Appliquées, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
Yousof YakoubLouvain Centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
Mihaly Palmai-PallagSecteur Des Sciences de La Santé, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Caroline BouzinIREC Imaging Platform (2IP; RRID:SCR_023378), Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
Laurence RyelandtInstitute of Mechanics, Materials and Civil Engineering, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Cristina PavanDepartment of Chemistry, University of Turin, Turin, Italy.
François HuauxLouvain Centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.
Dominique LisonLouvain Centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The industrial uses of titanium dioxide (TiO

Indexed as

Macrophages, AlveolarTitaniumTranscriptomeAnimalsCells, CulturedGene Expression ProfilingMaleParticle SizeRatsRats, Sprague-DawleyTitaniumtitanium dioxideGene signatureImpaired lung clearanceParticle comparisonParticle reactivityRat pulmonary toxicity

Identifiers

PMID40841704
PMCPMC12534340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.